New Dopamine Agonist for Parkinson's, Artificial Intelligence in Medical Journals, Coffee and Dementia Risk

5/21/2026

Neurology Today in 5

0:00

4:32

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a new selective dopamine agonist for people with Parkinson's disease, the use of artificial intelligence in preparing journal manuscripts, and caffeinated coffee's role in reducing dementia risk.

More episodes from "Neurology Today in 5"

OCEANIC-STROKE Study Results, High-Dose Flu Vaccine and Alzheimer's Risk, Role of Osteopathic Medicine in Neurology
vor 2 Tagen
4:54
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about asundexian reducing recurrent ischemic stroke, the link between the high-dose flu vaccine and Alzheimer's dementia incidence, and the evolving role of osteopathic medicine in neurology.
Wait Times for New Neurology Visits, Post-Traumatic Headache Severity in Children, New Drug for Alzheimer's Agitation
6/18/2026
4:54
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about appointment wait times for commercially insured patients, post-traumatic headache severity in children with a family history of migraine, and the FDA approval of a drug for Alzheimer's agitation.
Don't miss an episode of “Neurology Today in 5” and subscribe to it in the GetPodcast app.
Meat Intake and Cognitive Decline, Geographic Distribution of Research Funding, Artificial Intelligence's Role in Neurology
6/4/2026
4:54
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a link between higher meat and slower cognitive decline in APOE34/44 carriers, the geographic distribution of research funding, and how artificial intelligence is reshaping neurology.
New Dopamine Agonist for Parkinson's, Artificial Intelligence in Medical Journals, Coffee and Dementia Risk
5/21/2026
4:32
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a new selective dopamine agonist for people with Parkinson's disease, the use of artificial intelligence in preparing journal manuscripts, and caffeinated coffee's role in reducing dementia risk.
Neurology Match Day Growth, Diabetes and Dementia Risk, Public Health Discourse
5/7/2026
4:57
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the increase in neurology residency matches this year, the risk of dementia in people with Type 1 diabetes, and the role of neurologists in the public health conversation.
Academic Jobs for Fellowship Graduates, Complex Neuromuscular Treatments, New Stroke Guideline
4/16/2026
5:12
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the academic job market for fellowship graduates, the challenges of today's complex neuromuscular therapies, and the changes made in a new stroke guideline.
Acetaminophen Use During Pregnancy, Air Pollution and Motor Neuron Disease, Fremanezumab for Pediatric Migraine
4/2/2026
5:06
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about acetaminophen use during pregnancy, the link between air pollution and motor neuron disease risk, and the use of fremanezumab for pediatric migraine.
ACGME neurocritical care accreditation, Jamaica hurricane aftermath, rituximab for multiple sclerosis
3/19/2026
4:46
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about ACGME neurocritical care accreditation, how neurologists in Jamaica are recovering from hurricane damage, and the use of rituximab maintenance dosing in multiple sclerosis.
West Nile Neuroinvasive Disease, NINDS Director's Departure, Advanced Practice Provider Educational Funding
3/5/2026
5:00
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about West Nile neuroinvasive disease, what's next after NINDS director Dr. Walter Koroshetz's departure, and changes to funding for advanced practice providers' education.
EMG Expertise, GLP-1s and Epilepsy, Astrocytoma Combination Therapy
2/19/2026
4:38
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma.

More Episodes

Get the whole world of podcasts with the free GetPodcast app.

Subscribe to your favorite podcasts, listen to episodes offline and get thrilling recommendations.

A company from

New Dopamine Agonist for Parkinson's, Artificial Intelligence in Medical Journals, Coffee and Dementia Risk

Neurology Today in 5

More episodes from "Neurology Today in 5"

OCEANIC-STROKE Study Results, High-Dose Flu Vaccine and Alzheimer's Risk, Role of Osteopathic Medicine in Neurology

Wait Times for New Neurology Visits, Post-Traumatic Headache Severity in Children, New Drug for Alzheimer's Agitation

Meat Intake and Cognitive Decline, Geographic Distribution of Research Funding, Artificial Intelligence's Role in Neurology

New Dopamine Agonist for Parkinson's, Artificial Intelligence in Medical Journals, Coffee and Dementia Risk

Neurology Match Day Growth, Diabetes and Dementia Risk, Public Health Discourse

Academic Jobs for Fellowship Graduates, Complex Neuromuscular Treatments, New Stroke Guideline

Acetaminophen Use During Pregnancy, Air Pollution and Motor Neuron Disease, Fremanezumab for Pediatric Migraine

ACGME neurocritical care accreditation, Jamaica hurricane aftermath, rituximab for multiple sclerosis

West Nile Neuroinvasive Disease, NINDS Director's Departure, Advanced Practice Provider Educational Funding

EMG Expertise, GLP-1s and Epilepsy, Astrocytoma Combination Therapy